Review
Canada reported October cannabis sales of C$389 million, up 9.5% from a year ago and the slowest annual growth to date.
I distributed this written material to 420 Investor subscribers during the week:
Here are some of this week's highlights for Focus List names:
Please check the Focus List, (which has technical, fundamental and valuation ratings as well as a market-cap table). To help track market caps, we maintain tables for the Canadian LPs and the American cannabis operators and ancillary companies.
There were comments in over 80 discussions in the Forum. Don't miss out on this most informative part of 420 Investor! Not familiar with the the Forum? This video will help! This is a great way to track your favorite tickers, even those not on the Focus List, and to get your questions answered quickly.
Market Performance
The Global Cannabis Stock Index posted a new all-time closing low of 9.55 on Thursday and a new intraday low of 9.40. It was slammed lower this week to 9.71, ending down 11.9% for the week. This was a lot worse than the 0.2% loss in the S&P 500, which is down 5.8% in December. The cannabis index has dropped 29.0% in December, and it has declined 13.8% thus far in Q4. This is worse than the +7.2% return in the S&P 500.